LBRX
LB Pharmaceuticals Inc
44.71
-0.23 (-0.51%)
52w low 14.40
50.16 high
84.8% of range
LBRX · 6M
—
O--
H--
L--
C--
Chg--
Gap--
Vol--
×avg--
σ--
SMA20--
SMA50--
SMA200--
RSI--
SPY--
DD--
Bench--
Sig--
Hist--
pinned · Esc to release
hover · click to pin · ← → step · drag to zoom · shift-drag to measure
SMA 20SMA 50
—Context
- Move across the chart.
Events in view
| Date | Kind | Event | Source |
|---|---|---|---|
| 2026-11-05 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-11-05 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-09-15 | filing | 8-K: officer / director change; Reg FD disclosure | SEC EDGAR |
| 2026-09-15 | filing | 424B3 (prospectus) | SEC EDGAR |
| 2026-09-03 | filing | 8-K: officer / director change; Reg FD disclosure | SEC EDGAR |
| 2026-09-03 | filing | 424B3 (prospectus) | SEC EDGAR |
| 2026-08-11 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-08-11 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-08-11 | filing | 424B3 (prospectus) | SEC EDGAR |
| 2026-07-29 | filing | 8-K: material agreement; unregistered sale of equity (dilution); Reg FD disclosure | SEC EDGAR |
| 2026-07-29 | filing | 424B3 (prospectus) | SEC EDGAR |
| 2026-07-22 | filing | 8-K: other events | SEC EDGAR |
| 2026-07-22 | filing | 424B3 (prospectus) | SEC EDGAR |
| 2026-06-10 | filing | 8-K: officer / director change | SEC EDGAR |
| 2026-06-10 | filing | 424B3 (prospectus) | SEC EDGAR |
| 2026-06-09 | filing | 8-K: shareholder vote | SEC EDGAR |
| 2026-06-09 | filing | 424B3 (prospectus) | SEC EDGAR |
| 2026-05-12 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-05-12 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-05-12 | filing | 424B3 (prospectus) | SEC EDGAR |
Performance
1D
-0.51%
5D
+9.45%
1M
+24.44%
3M
-1.48%
6M
+38.38%
YTD
+100.85%
1Y
+179.79%
2Y
--
3Y
--
5Y
--
MAX
+183.15%
Period
+39.72%
High
50.16
Low
26.37
Ann Vol
41.70%
Sharpe
0.93
Max DD
-31.29%
ATR (14)
2.52